Literature DB >> 20513806

Deep venous thrombosis or pulmonary embolism and factor V Leiden: enigma or paradox.

Javier Corral, Vanessa Roldán, Vicente Vicente.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20513806      PMCID: PMC2878781          DOI: 10.3324/haematol.2010.023432

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  24 in total

1.  Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism.

Authors:  P de Moerloose; G Reber; A Perrier; T Perneger; H Bounameaux
Journal:  Br J Haematol       Date:  2000-07       Impact factor: 6.998

2.  Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation.

Authors:  B Manten; R G Westendorp; T Koster; P H Reitsma; F R Rosendaal
Journal:  Thromb Haemost       Date:  1996-10       Impact factor: 5.249

3.  Resistance to activated protein C in an unselected population of patients with pulmonary embolism.

Authors:  S Desmarais; P de Moerloose; G Reber; P Minazio; A Perrier; H Bounameaux
Journal:  Lancet       Date:  1996-05-18       Impact factor: 79.321

4.  Prevalence of factor V Leiden and prothrombin 20210 A variant in Bulgarian patients with pulmonary thromboembolism and deep venous thrombosis.

Authors:  B Boyanovsky; M Russeva; V Ganev; M Penev; M Baleva; M Russev
Journal:  Blood Coagul Fibrinolysis       Date:  2001-12       Impact factor: 1.276

5.  A prospective study of venous thromboembolism in relation to factor V Leiden and related factors.

Authors:  Aaron R Folsom; Mary Cushman; Michael Y Tsai; Nena Aleksic; Susan R Heckbert; Lori L Boland; Albert W Tsai; N David Yanez; Wayne D Rosamond
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

6.  Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism.

Authors:  M Margaglione; V Brancaccio; D De Lucia; I Martinelli; A Ciampa; E Grandone; G Di Minno
Journal:  Chest       Date:  2000-11       Impact factor: 9.410

7.  Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.

Authors:  J Emmerich; F R Rosendaal; M Cattaneo; M Margaglione; V De Stefano; T Cumming; V Arruda; A Hillarp; J L Reny
Journal:  Thromb Haemost       Date:  2001-09       Impact factor: 5.249

8.  Factor V Leiden and the risk for venous thromboembolism in the adult Danish population.

Authors:  Klaus Juul; Anne Tybjaerg-Hansen; Peter Schnohr; Børge G Nordestgaard
Journal:  Ann Intern Med       Date:  2004-03-02       Impact factor: 25.391

9.  An antifibrinolytic mechanism describing the prothrombotic effect associated with factor VLeiden.

Authors:  L Bajzar; M Kalafatis; P Simioni; P B Tracy
Journal:  J Biol Chem       Date:  1996-09-20       Impact factor: 5.157

Review 10.  The relationship between FV Leiden and pulmonary embolism.

Authors:  W Craig Hooper; Christine De Staercke
Journal:  Respir Res       Date:  2001-11-19
View more
  3 in total

1.  Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism.

Authors:  Olga V Gran; Erin N Smith; Sigrid K Brækkan; Hilde Jensvoll; Terry Solomon; Kristian Hindberg; Tom Wilsgaard; Frits R Rosendaal; Kelly A Frazer; John-Bjarne Hansen
Journal:  Haematologica       Date:  2016-06-16       Impact factor: 9.941

2.  A case of pulmonary thromboembolism due to coagulation factor V Leiden in Japan ~ usefulness of next generation sequencing~.

Authors:  Daisuke Sueta; Miwa Ito; Mitsuhiro Uchiba; Kenji Sakamoto; Eiichiro Yamamoto; Yasuhiro Izumiya; Sunao Kojima; Koichi Kaikita; Satoru Shinriki; Seiji Hokimoto; Hirotaka Matsui; Kenichi Tsujita
Journal:  Thromb J       Date:  2017-03-14

3.  To determine the frequency of Factor V Leiden in cases of Deep Vein Thrombosis and Healthy controls.

Authors:  Anjum Saeed; Muhammad Ali Kashif
Journal:  Pak J Med Sci       Date:  2015 Sep-Oct       Impact factor: 1.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.